KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 149 filers reported holding KURA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $196 | -1.5% | 16 | 0.0% | 0.00% | – |
Q4 2022 | $199 | – | 16 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 16 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 16 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 16 | +700.0% | 0.00% | – |
Q4 2021 | $0 | – | 2 | -88.2% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 17 | -39.3% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 28 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 28 | -37.8% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 45 | -4.3% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 47 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 47 | -23.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 61 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 61 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 61 | -1.6% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | – | 62 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |